Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1057

1.

The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.

Lwin TM, Hoffman RM, Bouvet M.

Expert Rev Anticancer Ther. 2018 May 16. doi: 10.1080/14737140.2018.1477593. [Epub ahead of print]

PMID:
29768067
2.

Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Elliott IA, Russell TA, Eckardt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM.

J Cell Biochem. 2018 May 8. doi: 10.1002/jcb.26792. [Epub ahead of print]

PMID:
29737543
3.

Exploiting methionine restriction for cancer treatment.

Chaturvedi S, Hoffman RM, Bertino JR.

Biochem Pharmacol. 2018 May 4;154:170-173. doi: 10.1016/j.bcp.2018.05.003. [Epub ahead of print] Review.

PMID:
29733806
4.

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Igarashi K, Kawaguchi K, Li S, Han Q, Tan Y, Gainor E, Kiyuna T, Miyake K, Miyake M, Higuchi T, Oshiro H, Singh AS, Eckardt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM.

Oncotarget. 2018 Apr 10;9(27):19263-19272. doi: 10.18632/oncotarget.24996. eCollection 2018 Apr 10.

5.

Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapy.

Miyake K, Kiyuna T, Miyake M, Kawaguchi K, Yoon SN, Zhang Z, Igarashi K, Razmjooei S, Wangsiricharoen S, Murakami T, Li Y, Nelson SD, Russell TA, Singh AS, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Singh SR, Endo I, Eilber FC, Hoffman RM.

Signal Transduct Target Ther. 2018 Apr 27;3:12. doi: 10.1038/s41392-018-0016-7. eCollection 2018.

6.

The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors.

Seaman AT, Dukes K, Hoffman RM, Christensen AJ, Kendell N, Sussman AL, Veléz-Bermúdez M, Volk RJ, Pagedar NA.

Patient Educ Couns. 2018 Apr 22. pii: S0738-3991(18)30192-7. doi: 10.1016/j.pec.2018.04.012. [Epub ahead of print]

PMID:
29709410
7.

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.

Rough K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K; PHACS and the IMPAACT P1025 Study Teams.

N Engl J Med. 2018 Apr 26;378(17):1593-1603. doi: 10.1056/NEJMoa1701666.

PMID:
29694825
8.

RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.

Sato K, Mori R, Hiroshima Y, Oba MS, Matsuyama R, Bouvet M, Hoffman RM, Endo I.

J Surg Res. 2018 Jun;226:122-130. doi: 10.1016/j.jss.2017.11.009. Epub 2018 Feb 22.

PMID:
29661277
9.

Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM.

Cell Cycle. 2018 May 21:1-6. doi: 10.1080/15384101.2018.1445907. [Epub ahead of print]

PMID:
29623758
10.

Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models.

Satake T, Suetsugu A, Nakamura M, Hasegawa K, Kunisada T, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Apr;38(4):1927-1935.

PMID:
29599308
11.

Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.

Wang W, Li Y, Chen Y, Chen H, Zhu P, Xu M, Wang H, Wu M, Yang Z, Hoffman RM, Gu Y.

Anticancer Res. 2018 Apr;38(4):1917-1925.

PMID:
29599307
12.

Visualizing the Tumor Microenvironment by Color-coded Imaging in Orthotopic Mouse Models of Cancer.

Suetsugu A, Shimizu M, Saji S, Moriwaki H, Hoffman RM.

Anticancer Res. 2018 Apr;38(4):1847-1857. Review.

PMID:
29599301
13.

Hand-Arm Bimanual Intensive Therapy Improves Prefrontal Cortex Activation in Children With Hemiplegic Cerebral Palsy.

Surkar SM, Hoffman RM, Willett S, Flegle J, Harbourne R, Kurz MJ.

Pediatr Phys Ther. 2018 Apr;30(2):93-100. doi: 10.1097/PEP.0000000000000486.

PMID:
29578992
14.

Imaging the Governing Step of Metastasis in Gelfoam® Histoculture.

Hoffman RM, Chishima T.

Methods Mol Biol. 2018;1760:215-220. doi: 10.1007/978-1-4939-7745-1_20.

PMID:
29572807
15.

Comparison of "Dimensionality" of Cancer Cell Culture in Gelfoam® Histoculture and Matrigel.

Tome Y, Uehara F, Kanaya F, Hoffman RM.

Methods Mol Biol. 2018;1760:205-214. doi: 10.1007/978-1-4939-7745-1_19.

PMID:
29572806
16.

Imaging DNA Repair After UV Irradiation Damage of Cancer Cells in Gelfoam® Histoculture.

Miwa S, Hoffman RM.

Methods Mol Biol. 2018;1760:199-203. doi: 10.1007/978-1-4939-7745-1_18.

PMID:
29572805
17.

Nerve Growth and Interaction in Gelfoam® Histoculture: A Nervous System Organoid.

Hoffman RM, Mii S, Duong J, Amoh Y.

Methods Mol Biol. 2018;1760:163-186. doi: 10.1007/978-1-4939-7745-1_16.

PMID:
29572803
18.

Hair Follicle-Associated Pluripotent (HAP) Stem Cells in Gelfoam® Histoculture for Use in Spinal Cord Repair.

Liu F, Hoffman RM.

Methods Mol Biol. 2018;1760:145-162. doi: 10.1007/978-1-4939-7745-1_15.

PMID:
29572802
19.

Hair-Shaft Growth in Gelfoam® Histoculture of Skin and Isolated Hair Follicles.

Hoffman RM, Li L, Cao W.

Methods Mol Biol. 2018;1760:133-144. doi: 10.1007/978-1-4939-7745-1_14.

PMID:
29572801
20.

Methionine Dependency Determination of Human Patient Tumors in Gelfoam® Histoculture.

Hoffman RM.

Methods Mol Biol. 2018;1760:125-131. doi: 10.1007/978-1-4939-7745-1_13.

PMID:
29572800
21.

In Vivo-Like Cell-Cycle Phase Distribution of Cancer Cells in Gelfoam® Histoculture Observed in Real Time by FUCCI Imaging.

Hoffman RM, Yano S.

Methods Mol Biol. 2018;1760:109-123. doi: 10.1007/978-1-4939-7745-1_12.

PMID:
29572799
22.

Clinical Usefulness of the Histoculture Drug Response Assay for Prostate Cancer and Benign Prostate Hypertrophy (BPH).

Hoffman RM.

Methods Mol Biol. 2018;1760:101-107. doi: 10.1007/978-1-4939-7745-1_11.

PMID:
29572798
23.

Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer.

Hoffman RM, Tanino H.

Methods Mol Biol. 2018;1760:93-100. doi: 10.1007/978-1-4939-7745-1_10.

PMID:
29572797
24.

Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.

Hoffman RM.

Methods Mol Biol. 2018;1760:83-92. doi: 10.1007/978-1-4939-7745-1_9.

PMID:
29572796
25.

Prospective Clinical Correlation of the Histoculture Drug Response Assay for Ovarian Cancer.

Hoffman RM, Jung PS, Kim MB, Nam JH.

Methods Mol Biol. 2018;1760:73-81. doi: 10.1007/978-1-4939-7745-1_8.

PMID:
29572795
26.

Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer.

Hoffman RM.

Methods Mol Biol. 2018;1760:61-72. doi: 10.1007/978-1-4939-7745-1_7.

PMID:
29572794
27.

Diagnosis and Pathological Analysis of Patient Cancers by Detection of Proliferating Cells in Gelfoam® Histoculture.

Hoffman RM.

Methods Mol Biol. 2018;1760:49-60. doi: 10.1007/978-1-4939-7745-1_6.

PMID:
29572793
28.

Development of the Histoculture Drug Response Assay (HDRA).

Hoffman RM, Vescio RA.

Methods Mol Biol. 2018;1760:39-48. doi: 10.1007/978-1-4939-7745-1_5.

PMID:
29572792
29.

Expression and Targeting of Tumor Markers in Gelfoam® Histoculture: Potential Individualized Assays for Immuno-Oncology.

Hoffman RM, Guadagni F.

Methods Mol Biol. 2018;1760:29-37. doi: 10.1007/978-1-4939-7745-1_4.

PMID:
29572791
30.

In Vivo-Like Growth Patterns of Multiple Types of Tumors in Gelfoam® Histoculture.

Hoffman RM, Freeman AE.

Methods Mol Biol. 2018;1760:19-28. doi: 10.1007/978-1-4939-7745-1_3.

PMID:
29572790
31.

3D Sponge-Matrix Histoculture: An Overview.

Hoffman RM.

Methods Mol Biol. 2018;1760:11-17. doi: 10.1007/978-1-4939-7745-1_2.

PMID:
29572789
32.

Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models.

Wang J, Yang X, Han H, Wang L, Bao W, Wang S, Hoffman RM, Yang M, Qi H, An C, Hu K.

Chin J Cancer Res. 2018 Feb;30(1):112-121. doi: 10.21147/j.issn.1000-9604.2018.01.12.

33.

Neural activation within the prefrontal cortices during the goal-directed motor actions of children with hemiplegic cerebral palsy.

Surkar SM, Hoffman RM, Harbourne R, Kurz MJ.

Neurophotonics. 2018 Jan;5(1):011021. doi: 10.1117/1.NPh.5.1.011021. Epub 2018 Mar 10.

PMID:
29541647
34.

Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.

Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Miyake K, Kiyuna T, Miyake M, Chemielwski B, Nelson SD, Russell TA, Dry SM, Li Y, Singh AS, Eckardt MA, Unno M, Eilber FC, Hoffman RM.

Oncotarget. 2018 Jan 17;9(13):11119-11125. doi: 10.18632/oncotarget.24264. eCollection 2018 Feb 16.

35.

Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.

Jun E, Hong SM, Yoo HJ, Kim MB, Won JS, An S, Shim IK, Chang S, Hoffman RM, Kim SC.

Oncotarget. 2017 Dec 21;9(8):7867-7881. doi: 10.18632/oncotarget.23567. eCollection 2018 Jan 30.

36.

Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Elliott IA, Russell TA, Eckardt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM.

Oncotarget. 2017 Dec 4;9(8):7774-7781. doi: 10.18632/oncotarget.22892. eCollection 2018 Jan 30.

37.

Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Singh AS, Eckardt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Singh SR, Eilber FC, Hoffman RM.

Biochem Biophys Res Commun. 2018 Mar 18;497(4):1055-1061. doi: 10.1016/j.bbrc.2018.02.174. Epub 2018 Feb 23.

PMID:
29481803
38.

Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.

Kramer MG, Masner M, Ferreira FA, Hoffman RM.

Front Microbiol. 2018 Jan 23;9:16. doi: 10.3389/fmicb.2018.00016. eCollection 2018.

39.

Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers.

Zeliadt SB, Hoffman RM, Birkby G, Eberth JM, Brenner AT, Reuland DS, Flocke SA.

Am J Prev Med. 2018 Apr;54(4):568-575. doi: 10.1016/j.amepre.2018.01.001. Epub 2018 Feb 21.

PMID:
29429606
40.

Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Taylor KL, Luta G, Hoffman RM, Davis KM, Lobo T, Zhou Y, Leimpeter A, Shan J, Jensen RE, Aaronson DS, Van Den Eeden SK.

Transl Behav Med. 2018 Mar 1;8(2):156-165. doi: 10.1093/tbm/ibx005.

PMID:
29425377
41.

Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.

Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Miyake K, Kiyuna T, Miyake M, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM.

Oncotarget. 2017 Dec 12;9(1):915-923. doi: 10.18632/oncotarget.23185. eCollection 2018 Jan 2.

42.

Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.

Kawaguchi K, Igarashi K, Kiyuna T, Miyake K, Miyake M, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Singh AS, Unno M, Eilber FC, Hoffman RM.

Cell Cycle. 2018;17(5):627-633. doi: 10.1080/15384101.2017.1421876. Epub 2018 Mar 29.

PMID:
29384032
43.

The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial.

Fatti G, Ngorima-Mabhena N, Chirowa F, Chirwa B, Takarinda K, Tafuma TA, Mahachi N, Chikodzore R, Nyadundu S, Ajayi CA, Mutasa-Apollo T, Mugurungi O, Mothibi E, Hoffman RM, Grimwood A.

Trials. 2018 Jan 29;19(1):79. doi: 10.1186/s13063-018-2469-y.

44.

Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li S, Han Q, Tan Y, Zhao M, Li Y, Nelson SD, Dry SM, Singh AS, Elliott IA, Russell TA, Eckardt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM.

Cell Cycle. 2018;17(6):801-809. doi: 10.1080/15384101.2018.1431596. Epub 2018 Apr 10.

PMID:
29374999
45.

Fluorescence-guided Surgery with Splenic Preservation Prevents Tumor Recurrence in an Orthotopic Nude-mouse Model of Human Pancreatic Cancer.

Hwang HK, Kang CM, Lee SH, Murakami T, Kiyuna T, Kim SH, Hoffman RM, Bouvet M.

Anticancer Res. 2018 Feb;38(2):665-670.

PMID:
29374688
46.

Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.

Lwin TM, Murakami T, Miyake K, Yazaki PJ, Shivley JE, Hoffman RM, Bouvet M.

Ann Surg Oncol. 2018 Apr;25(4):1079-1085. doi: 10.1245/s10434-018-6344-6. Epub 2018 Jan 25.

PMID:
29372363
47.

Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Miyake K, Kawaguchi K, Kiyuna T, Miyake M, Igarashi K, Zhang Z, Murakami T, Li Y, Nelson SD, Elliott I, Russell T, Singh A, Hiroshima Y, Momiyama M, Matsuyama R, Chishima T, Endo I, Eilber FC, Hoffman RM.

Cell Cycle. 2018;17(6):722-727. doi: 10.1080/15384101.2017.1423223.

PMID:
29334307
48.

Engineered mesenchymal stem-cell-sheets patches prevents postoperative pancreatic leakage in a rat model.

Kim SR, Yi HJ, Lee YN, Park JY, Hoffman RM, Okano T, Shim IK, Kim SC.

Sci Rep. 2018 Jan 10;8(1):360. doi: 10.1038/s41598-017-18490-9.

49.

Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma.

Igarashi K, Kawaguchi K, Li S, Han Q, Tan Y, Murakami T, Kiyuna T, Miyake K, Miyake M, Singh AS, Eckardt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Singh SR, Eilber FC, Hoffman RM.

Cancer Lett. 2018 Mar 28;417:168-173. doi: 10.1016/j.canlet.2017.12.028. Epub 2018 Jan 3.

PMID:
29306021
50.

Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.

Fang T, Huang H, Li X, Liao J, Yang Z, Hoffman RM, Cheng XI, Liang L, Hu W, Yun S.

Anticancer Res. 2018 Jan;38(1):179-186.

PMID:
29277771

Supplemental Content

Loading ...
Support Center